EVOGENE LTD (EVGN) Stock News

USA - NASDAQ:EVGN - IL0011050551 - Common Stock

1.16 USD

-0.01 (-0.85%)

Last: 11/19/2025, 2:52:48 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

EVGN Latest News, Press Relases and Analysis

All

Press Releases

10 hours ago - By: Benzinga

What's Next: Evogene's Earnings Preview

9 days ago - By: Casterra Ag Ltd.

Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming

3 months ago - By: Evogene

Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York

3 months ago - By: Evogene

Evogene Reports Second Quarter 2025 Financial Results

3 months ago - By: Benzinga - Mentions: KEYS ZTO AS ITRN ...

Earnings Scheduled For August 19, 2025

6 months ago - By: Evogene

Evogene Reports First Quarter 2025 Financial Results

3 months ago - By: Evogene Ltd

Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases

4 months ago - By: Evogene

Evogene Schedules Second Quarter 2025 Financial Results Release

5 months ago - By: Stocktwits - Mentions: GOOG

Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud

a year ago - By: Evogene

Evogene Reports Third Quarter 2024 Financial Results

5 months ago - By: Evogene

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

7 months ago - By: Evogene

Evogene Schedules First Quarter 2025 Financial Results Release

7 months ago - By: Yahoo Finance - Mentions: TSLA

Why Evogene Ltd. (EVGN) Soared on Monday

7 months ago - By: Lavie Bio

ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio

9 months ago - By: Evogene

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

9 months ago - By: Evogene

Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025

9 months ago - By: Evogene

Evogene Schedules Fourth Quarter 2024 Financial Results Release

a year ago - By: Lavie Bio

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

a year ago - By: Lavie Bio

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

a year ago - By: Evogene

Evogene Schedules Third Quarter 2024 Financial Results Release

a year ago - By: Casterra Ag Ltd.

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

a year ago - By: Lavie Bio

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals